tiprankstipranks
Advertisement
Advertisement

CNSP Stock Latest News

CNS Pharmaceuticals Unveils Strategic Pivot to Broader Oncology
Company AnnouncementsCNS Pharmaceuticals Unveils Strategic Pivot to Broader Oncology
16d ago
8K
CNSP
CNS Pharmaceuticals launches new corporate growth strategy
PremiumThe Fly
CNS Pharmaceuticals launches new corporate growth strategy
16d ago
CNSP
CNS Pharmaceuticals Appoints New Chief Medical Officer
PremiumCompany Announcements
CNS Pharmaceuticals Appoints New Chief Medical Officer
25d ago
8K
CNSP
CNS Pharmaceuticals appoints Lynne Kelley as CMO
PremiumThe Fly
CNS Pharmaceuticals appoints Lynne Kelley as CMO
25d ago
CNSP
CNS Pharmaceuticals Restructures Finance Leadership, Appoints New CFO
PremiumCompany Announcements
CNS Pharmaceuticals Restructures Finance Leadership, Appoints New CFO
1M ago
8K
CNSP
CNS Pharmaceuticals appoints Steven O’Loughlin as CFO, Dylan Wenke as CBO
PremiumThe FlyCNS Pharmaceuticals appoints Steven O’Loughlin as CFO, Dylan Wenke as CBO
1M ago
CNSP
CNS Pharmaceuticals says priority ‘is to transform’ how company operates
Premium
The Fly
CNS Pharmaceuticals says priority ‘is to transform’ how company operates
2M ago
CNSP
CNS Pharmaceuticals Inc trading resumes
Premium
The Fly
CNS Pharmaceuticals Inc trading resumes
2M ago
CNSP
CNS Pharmaceuticals Inc trading halted, volatility trading pause
PremiumThe Fly
CNS Pharmaceuticals Inc trading halted, volatility trading pause
2M ago
CNSP
CNS Pharmaceuticals Announces New CEO Appointment
PremiumCompany Announcements
CNS Pharmaceuticals Announces New CEO Appointment
3M ago
8K
CNSP
CNS Pharmaceuticals CEO John Climaco steps down, Rami Levin succeeds
PremiumThe Fly
CNS Pharmaceuticals CEO John Climaco steps down, Rami Levin succeeds
3M ago
CNSP
CNS Pharmaceuticals Increases Authorized Shares for Growth
PremiumCompany Announcements
CNS Pharmaceuticals Increases Authorized Shares for Growth
4M ago
8K
CNSP
CNS Pharmaceuticals: Promising Drug Pipeline and Strategic Plans Drive Buy Rating
PremiumRatingsCNS Pharmaceuticals: Promising Drug Pipeline and Strategic Plans Drive Buy Rating
4M ago
CNSP
CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D
Premium
Company Announcements
CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D
4M ago
CNSP
CNS Pharmaceuticals reports Q3 EPS ($5.76) vs. ($153.20) last year
Premium
The Fly
CNS Pharmaceuticals reports Q3 EPS ($5.76) vs. ($153.20) last year
4M ago
CNSP
CNS Pharmaceuticals sees cash runway into 2H26
PremiumThe Fly
CNS Pharmaceuticals sees cash runway into 2H26
4M ago
CNSP
CNS Pharmaceuticals upgraded to Buy at Maxim on TPI-287 roadmap
PremiumThe Fly
CNS Pharmaceuticals upgraded to Buy at Maxim on TPI-287 roadmap
7M ago
CNSP
CNS Pharmaceuticals upgraded to Buy from Hold at Maxim
PremiumThe Fly
CNS Pharmaceuticals upgraded to Buy from Hold at Maxim
7M ago
CNSP
CNS Pharmaceuticals reports Q2 EPS ($6.42) vs. ($4,049.20) last year
PremiumThe Fly
CNS Pharmaceuticals reports Q2 EPS ($6.42) vs. ($4,049.20) last year
7M ago
CNSP
CNS Pharmaceuticals sees cash runway into 2H26
PremiumThe FlyCNS Pharmaceuticals sees cash runway into 2H26
7M ago
CNSP
CNS Pharmaceuticals Reports Q2 2025 Financial Results
Premium
Company Announcements
CNS Pharmaceuticals Reports Q2 2025 Financial Results
7M ago
CNSP
CNS Pharmaceuticals Announces Reverse Stock Split
Premium
Company Announcements
CNS Pharmaceuticals Announces Reverse Stock Split
8M ago
8K
CNSP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >